Role of the p53 homolog p73 in cancer
Role of the p53 homolog p73 in cancer
批准号:
7487702
负责人:
UTE Martha MOLL
金额:
$7.75万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-01-14 至 2008-07-31
关键词:
AblationAlternative SplicingAttentionComplexConflict (Psychology)ConsensusDataDevelopmentDoctor of MedicineEmployee StrikesExhibitsFamily memberGenesGeneticGrantHistocompatibility TestingHomologous GeneHumanIndividualMalignant NeoplasmsMusMutationNatureNormal tissue morphologyOncogenicPlayPrincipal InvestigatorProtein IsoformsRoleSpecificityTP53 geneTitleTumor Suppressor Proteinsabstractingbasebiological adaptation to stressin vivoprogramspromotertumorvirtual
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Principal Investigator/Program Director (Last, first, middle): Moll, Ute, M
Title: the Role of p63 and p73 in Cancer
PI: Ute M. Moll, M.D.
Abstract
p53 controls a powerful stress response and is a quintessential tumor suppressor. The discovery of p63 and
p73, two p53 family members, provoked much speculation about their individual and collective functions.
However, while a strong consensus exists that both genes play a major role in cancer, current data is
conflicting whether their nature is tumor suppressive, oncogenic or in some context both. Although their
function in development was immediately apparent from gene ablation studies, delineating their exact role in
cancer remains elusive due to a lack of clear genetic data in humans and mice. Due to a second internal
promoter and alternative splicing, p63 and p73 are complex bipolar genes giving rise to multiple isoforms that
can simplistically be viewed as Two Opposing-Genes-in-One. Moreover, in sharp contrast to the ubiquitous
mutational alteration of p53, p63 and p73 are characterized by a virtual absence of inactivating mutations,
and instead exhibit aberrant expression of specific isoforms in tumors.
This grant aims at elucidating the in vivo role of both genes in specific oncogenic contexts and is
based on two premises. First, normal tissues exhibit a striking specificity for tissue types and isoforms in their
p63 and p73 expression, an important fact that up to now received little attention, yet likely holds the
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A novel role for E2fs: E2f7 and E2f8 control motile ciliogenesis
-
批准号:10450815
-
项目类别:
-
资助金额:$57.72万
-
财政年份:2021
-
负责人:UTE Martha MOLL
-
依托单位:
A novel role for E2fs: E2f7 and E2f8 control motile ciliogenesis
-
批准号:10656259
-
项目类别:
-
资助金额:$58.68万
-
财政年份:2021
-
负责人:UTE Martha MOLL
-
依托单位:
A novel role for E2fs: E2f7 and E2f8 control motile ciliogenesis
-
批准号:10293097
-
项目类别:
-
资助金额:$57.24万
-
财政年份:2021
-
负责人:UTE Martha MOLL
-
依托单位:
Targeting stabilized mutant p53 protein
-
批准号:9038330
-
项目类别:
-
资助金额:$35.65万
-
财政年份:2013
-
负责人:UTE Martha MOLL
-
依托单位:
Targeting stabilized mutant p53 protein
-
批准号:8496336
-
项目类别:
-
资助金额:$33.28万
-
财政年份:2013
-
负责人:UTE Martha MOLL
-
依托单位:
Mutant p53 as actionable cancer-specific target
-
批准号:10414801
-
项目类别:
-
资助金额:$33.75万
-
财政年份:2013
-
负责人:UTE Martha MOLL
-
依托单位:
Targeting stabilized mutant p53 protein
-
批准号:8827721
-
项目类别:
-
资助金额:$35.65万
-
财政年份:2013
-
负责人:UTE Martha MOLL
-
依托单位:
Targeting stabilized mutant p53 protein
-
批准号:8640903
-
项目类别:
-
资助金额:$34.55万
-
财政年份:2013
-
负责人:UTE Martha MOLL
-
依托单位:
Mutant p53 as actionable cancer-specific target
-
批准号:10162515
-
项目类别:
-
资助金额:$34.44万
-
财政年份:2013
-
负责人:UTE Martha MOLL
-
依托单位:
Third International Mdm2 Workshop
-
批准号:7000510
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2005
-
负责人:UTE Martha MOLL
-
依托单位:
Role of the p53 homolog p73 in cancer
-
批准号:7008208
-
项目类别:
-
资助金额:$29.43万
-
财政年份:2002
-
负责人:UTE Martha MOLL
-
依托单位:
Role of the p53 homolog p73 in cancer
-
批准号:6687834
-
项目类别:
-
资助金额:$30.14万
-
财政年份:2002
-
负责人:UTE Martha MOLL
-
依托单位:
The role of p63 and p73 in cancer
-
批准号:7806553
-
项目类别:
-
资助金额:$31.43万
-
财政年份:2002
-
负责人:UTE Martha MOLL
-
依托单位:
Role of the p53 homolog p73 in cancer
-
批准号:6422548
-
项目类别:
-
资助金额:$30.14万
-
财政年份:2002
-
负责人:UTE Martha MOLL
-
依托单位:
Role of the p53 homolog p73 in cancer
-
批准号:6921975
-
项目类别:
-
资助金额:$30.14万
-
财政年份:2002
-
负责人:UTE Martha MOLL
-
依托单位:
The role of p63 and p73 in cancer
-
批准号:8058629
-
项目类别:
-
资助金额:$30.52万
-
财政年份:2002
-
负责人:UTE Martha MOLL
-
依托单位:
The role of p63 and p73 in cancer
-
批准号:8252224
-
项目类别:
-
资助金额:$30.52万
-
财政年份:2002
-
负责人:UTE Martha MOLL
-
依托单位:
The role of p63 and p73 in cancer
-
批准号:7659627
-
项目类别:
-
资助金额:$31.26万
-
财政年份:2002
-
负责人:UTE Martha MOLL
-
依托单位:
Role of the p53 homolog p73 in cancer
-
批准号:6620858
-
项目类别:
-
资助金额:$30.14万
-
财政年份:2002
-
负责人:UTE Martha MOLL
-
依托单位:
The role of p63 and p73 in cancer
-
批准号:7526775
-
项目类别:
-
资助金额:$23.54万
-
财政年份:2002
-
负责人:UTE Martha MOLL
-
依托单位:
海外基金